Skip to content
DilutionScan
Atrium Therapeutics, Inc. logo
RNA$6.43-14.38%

Atrium Therapeutics, Inc.

Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq

Mkt Cap & EV$138.7M /
Float & O/S15.88M / 21.57M
Est. Net Cash/Sh
Inst Own64.3%

DilutionScan read 28 of Atrium Therapeutics, Inc.'s SEC filings and found 1 warrant series and 1 completed offering on file for RNA. The latest dilution event on file is an offering on Oct 9, 2026. Analysis updated Nov 14, 2026.

Signal8 Summary

DilutionScanEvery instrument in full · From $29.99/mo